Quest Diagnostics Incorporated (DGX) is a Healthcare · Diagnostics & Research company listed on NYSE. Price $246.55 (-0.36%), Market cap $21.01B, P/E ratio 20.61, 52-week low–high $166.42 ~ $211.91.
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service c
Financial statements, price targets, institutional (13F) holdings and related news for Quest Diagnostics Incorporated are updated in real time on BlackAll Trade.
Quest Diagnostics Incorporated trades at $246.55 (-0.36%). Real-time quotes and charts are available on BlackAll Trade.
Quest Diagnostics Incorporated has a market cap of about $21.01B. Its P/E ratio is 20.61.
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanc